The primary objective of this study is to evaluate the safety and tolerability of single and multiple IV doses of MEDI-546 in adult subjects with scleroderma who have skin thickening in an area suitable for repeat biopsy.
To evaluate the safety and tolerability of a multiple-dosed drug (MEDI-546) in adults with scleroderma.